Hemispherx Biopharma, Inc. (HEB) Reports Q2 Loss of $0.02

Hemispherx Biopharma, Inc. (NYSE: HEB) reported Q2 EPS of ($0.02), versus ($0.02) reported last year.

For earnings history and earnings-related data on Hemispherx Biopharma, Inc. (HEB) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c